These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30686091)

  • 21. The inhibitory effect of tocilizumab on systemic bone loss and tendon inflammation in a juvenile Collagen-Induced arthritis rat model.
    Poutoglidou F; Pourzitaki C; Manthou ME; Samoladas E; Saitis A; Malliou F; Kouvelas D
    Connect Tissue Res; 2022 Nov; 63(6):577-589. PubMed ID: 35175165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting interleukin-6 in pediatric rheumatic diseases.
    De Benedetti F
    Curr Opin Rheumatol; 2009 Sep; 21(5):533-7. PubMed ID: 19593141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
    Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of tocilizumab in the treatment of juvenile idiopathic arthritis.
    Machado SH; Xavier RM
    Expert Opin Drug Saf; 2017 Apr; 16(4):493-500. PubMed ID: 28277841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biologic response modifiers for juvenile idiopathic arthritis].
    Yokota S
    Nihon Rinsho; 2007 Jul; 65(7):1331-5. PubMed ID: 17642252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
    Otten MH; Anink J; Spronk S; van Suijlekom-Smit LW
    Ann Rheum Dis; 2013 Nov; 72(11):1806-12. PubMed ID: 23172748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent therapeutic advances in juvenile idiopathic arthritis.
    Giancane G; Alongi A; Rosina S; Tibaldi J; Consolaro A; Ravelli A
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):476-487. PubMed ID: 29773268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interleukin-6 inhibition as a potential therapeutic target in rheumatic diseases].
    Iking-Konert C; Bartz-Bazzanella P; Falagan D; Hofman MW; Schwarting A; Dörner T
    Z Rheumatol; 2014 Apr; 73(3):269-76. PubMed ID: 24166363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Juvenile idiopathic arthritis: therapies in the 21st century.
    Haines KA
    Bull NYU Hosp Jt Dis; 2007; 65(3):205-11. PubMed ID: 17922671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologics for the Treatment of Juvenile Idiopathic Arthritis.
    Poddighe D; Romano M; Gattinara M; Gerloni V
    Curr Med Chem; 2018; 25(42):5860-5893. PubMed ID: 29788871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab.
    Kawada J; Iwata N; Kitagawa Y; Kimura H; Ito Y
    Mod Rheumatol; 2012 Aug; 22(4):565-70. PubMed ID: 22057635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis.
    Barnes MG; Grom AA; Thompson SD; Griffin TA; Pavlidis P; Itert L; Fall N; Sowders DP; Hinze CH; Aronow BJ; Luyrink LK; Srivastava S; Ilowite NT; Gottlieb BS; Olson JC; Sherry DD; Glass DN; Colbert RA
    Arthritis Rheum; 2009 Jul; 60(7):2102-12. PubMed ID: 19565513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.
    Woerner A; von Scheven-Gête A; Cimaz R; Hofer M
    Expert Rev Clin Immunol; 2015 May; 11(5):575-88. PubMed ID: 25843554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis.
    Yokota S; Miyamae T; Imagawa T; Katakura S; Kurosawa R; Mori M
    Clin Rev Allergy Immunol; 2005 Jun; 28(3):231-8. PubMed ID: 16129907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab.
    Horneff G; Klein A; Klotsche J; Minden K; Huppertz HI; Weller-Heinemann F; Kuemmerle-Deschner J; Haas JP; Hospach A
    Arthritis Res Ther; 2016 Nov; 18(1):272. PubMed ID: 27881144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
    Woodrick RS; Ruderman EM
    Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis.
    Hinze C; Fuehner S; Kessel C; Wittkowski H; Lainka E; Baehr M; Hügle B; Haas JP; Ganser G; Weißbarth-Riedel E; Jansson A; Foell D
    Arthritis Rheumatol; 2020 Mar; 72(3):499-505. PubMed ID: 31599092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
    Yokota S; Kikuchi M; Nozawa T; Kanetaka T; Sato T; Yamazaki K; Sakurai N; Hara R; Mori M
    Mod Rheumatol; 2015 Jan; 25(1):1-10. PubMed ID: 24842480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease.
    Cimaz R; Von Scheven A; Hofer M
    Swiss Med Wkly; 2012; 142():w13582. PubMed ID: 22573189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.